Avalo Therapeutics Inc. buy Oppenheimer Holdings Inc.
Start price
16.04.24
/
50%
€0.041
Target price
16.04.25
-
Performance (%)
-
End price
17.04.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Avalo Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 1,16 % | 3,68 % | 4,55 % |
| iShares Nasdaq 100 | 2,59 % | 3,10 % | 36,50 % |
| iShares Nikkei 225® | 7,11 % | 10,60 % | 61,22 % |
| iShares S&P 500 | 1,26 % | 1,67 % | 25,23 % |
Comments by Oppenheimer_Holdings for this prediction
In the thread Avalo Therapeutics Inc. diskutieren
Avalo Therapeutics, Inc. (NASDAQ: AVTX) was upgraded by analysts at Oppenheimer Holdings Inc. from a "market perform" rating to an "outperform" rating.
Ratings data for AVTX provided by MarketBeat
In the thread Trading Avalo Therapeutics Inc.
Die von Oppenheimer_Holdings gewählte maximale Laufzeit wurde überschritten